A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma (PACT-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01730222
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : September 1, 2017
Information provided by (Responsible Party):
Michele Reni, IRCCS San Raffaele